Mammalian hematopoiesis is a hierarchical and highly dynamic process (Ghaffari, 2008) . This rapid and regulated program is sustained by a rare population of relatively quiescent hemato poietic stem cells (HSCs) that continuously gen erate hematopoietic progenitor cells (HPCs) . HPCs are the workhorses in hematopoiesis and are critical for homeostasis of the blood system, as they are primarily responsible for the expan sion of HSC progenies and generating differen tiated blood cells. HPCs are therefore endowed with a very high proliferation potential. Conse quently, a precise yet flexible regulatory program of HPC division is crucial to the maintenance of blood cell homeostasis under normal and stress conditions, the malfunction of which can cause a variety of hematologic diseases including BM failure, anemia, leukemia, and lymphoma (Boggs and Boggs, 1976; Bonnet and Dick, 1997; Castor et al., 2005) . Thus, elucidating the mech anisms governing HPC proliferation and dif ferentiation is of great significance.
The homeostasis of hematopoietic stem and progenitor cells (HSPCs) relies on, among other mechanisms, tightly controlled cell cycle and survival machineries. Molecules involved in regu lating the cell cycle, such as p16 Ink4A , p21 Cip1/Waf1 , p27 Kip1 , PTEN, and Egr1, and those regulat ing cell survival and apoptosis, such as p53, Bcl2, Bclx, and Mcl1, are essential for the mainte nance of HSPCs (Cheng et al., 2000a,b; Arai et al., 2004; Kozar et al., 2004; Janzen et al., 2006; Yilmaz et al., 2006; Zhang et al., 2006; Min et al., 2008; Zou et al., 2011) . However, a more detailed picture of the ma chinery governing cell cycle progression, especially how cyto kinesis is regulated during hematopoiesis, is currently not available. Cytokinesis is central for determining the identities of daughter cells upon division because it separates genetic materials, patterns cytosolic cell fate determinants, and deter mines the relative positions of the daughter cells to the niche (Knoblich, 2008) . Mitotic failure can lead to aneuploidy and genomic instability, which may result in cell death (Castedo et al., 2004a) or transformation (Storchova and Pellman, 2004; Ganem et al., 2007) . In addition, because HSCs and HPCs are different in proliferative kinetics, distinct cytokinesis machineries might be essential to maintain a relative quiescent stem cell pool and an actively dividing progenitor population. Defining regulatory mechanisms of cytokinesis of primitive hematopoiesis cells, and understanding mechanistic relation ships between cell cycle abnormalities and cell death control, may result in more detailed knowledge of the regulatory ma chineries for critical steps in hematopoiesis.
Ras homologue gene family, member A (RhoA) is among the first members of the Rho GTPase family identified and is best known as a critical regulator of cytoskeleton dynamics. It cycles between the GTPbound active and GDPbound inactive forms in response to diverse cellular stimuli under tight regulation (Van Aelst and D'SouzaSchorey, 1997) . Upon activation (i.e., RhoAGTP), RhoA transduces signals to downstream effectors to elicit cell functions including cell adhesion, survival, cell cycle progression, and transcription; studies have reported a critical involvement of RhoA in regu lating cytokinesis (Jaffe and Hall, 2005) . Active RhoA and its downstream signaling components such as Factin, myosin, and annilin are concentrated at the cleavage furrow during cytokinesis. Disruption of this process results in cytokinesis failure and multinucleated cells (Piekny et al., 2005) . How ever, our current knowledge about RhoA function is mostly derived from dominantnegative or constitutively active mutant overexpression studies performed in cultured cell lines, which are limited by specificity and dosage issues in their physio logical implications. Models in which RhoA is genetically deleted are better systems to define the role of RhoA in tissue/ cell type-specific physiological conditions. To this end, several recent conditional genetargeting studies in mouse models have begun to reveal the unique and important functions of RhoA in various mammalian organs (Geh et al., 2011; Jackson et al., 2011; Melendez et al., 2011; Xiang et al., 2011; Pleines et al., 2012; Zhang et al., 2012 ). It appears that RhoA signaling function is cell type and pathway dependent, and many pre viously suggested cellular roles of RhoA may not be applica ble to complex biological processes in vivo.
In this study, we investigate the role of RhoA in regulating HSPCs and hematopoiesis using an inducible RhoA condi tional KO (cKO) Ar ticle 2373 response to RhoA deletion and died 1 wk after poly I:C in duction. By 5 d after poly I:C injections, RhoA deficiency re sulted in a rapid and significant decrease of neutrophils (0.54 ± 0.09 k/µl in RhoAcKO mice vs. 3.64 ± 0.18 k/µl in control) and a significant reduction of monocytes and platelets in the peripheral blood (PB; Fig. 1 , G and H). In the erythroid lineage, RhoA deficiency resulted in a small but significant reduction of red blood cells (Fig. 1 H) . RhoA deficiency did not alter the count of circulating lymphocytes in this experimental setup (Fig. 1 G) , as these lineages usually posed a longer life span the floxed allele in the BM of Mx-Cre + ; RhoA fl/+ heterozy gous mice did not affect RhoA protein expression nor cause detectable hematopoietic defects (not depicted).
Although the Mx-cre-mediated gene targeting models have been broadly used in hematopoietic studies, gene KO is not limited to the blood system (Kühn et al., 1995) . To specifically delete RhoA from the hematopoietic lineages, we induced RhoA deletion after transplantation of BM cells from Mx-cre + ; RhoA fl/fl mice into congenic CD45.1 + recipients. The recipients presented with multilineage cytopenia in 
RhoA is required for hematopoietic homeostasis in competitive transplantation
In RhoAcKO mice, severe HPC loss correlates with an acute reduction of differentiated hematopoietic cells. The loss of progenitor cells may be causal for the loss of mature cells. How ever, it is also possible that the loss of mature cells may lead to a feedback exhaustion of progenitors. In addition, although phenotypic HSCs are preserved in the RhoAcKO mice, we could not determine the longterm functionality of the HSCs using the previous model as a result of the rapid death of RhoAcKO mice after poly I:C inductions. A competitive trans plantation experiment could address these concerns because of the presence of WT competitor cells, thus avoiding com pensational activation/exhaustion of progenitors and sustain ing the survival of the recipients to allow longterm functional analysis of donor HSCs, including secondary transplants.
Consistent with the data from the noncompetitive trans plantation experiment, upon deletion of RhoA we observed a rapid and persistent reduction of donorderived (RhoA / , CD45.2 + ) blood cells in the peripheral circulation in the competitive transplant model. This reduction was observed in all major blood lineages (myeloid, T, and B cell lineages; Fig. 3 ), demonstrating that the hematopoieticautonomous absence of RhoA impairs multilineage hematopoiesis.
RhoA is essential for HPC activity but is dispensable for the maintenance of HSCs To study the functionality of RhoAnull HSCs and progeni tors, we examined the frequency of donorderived (CD45.2 + ) LSK and LK cells in the competitive transplantation model. We found that RhoAdeficient LK cells were not capable of competing with competitor cells. 5 mo after secondary trans plantation, the percentage of donor derived (CD45.2 + ) LK cells dropped to 15% of the original (Fig. 4, A and B) . In con trast, deletion of RhoA did not significantly affect the more than the relatively short time course (1 wk) of this experiment. Subsequent competitive transplantation experiments, though, showed that RhoA was also critical for the development of lymphocytes (see Fig. 3, C and D) .
Consistent with decreased number of cells in the periphery, we observed a significant reduction of BM cellularity. Hema toxylin and eosin (H&E) histology examination showed a drastic reduction of major blood cell types, including both myeloid and erythroid cells (Fig. 1 I) . Consistently, total white blood cells in tibia, femur, and iliac crest in RhoAcKO mice were reduced from 176.2 ± 16.2 × 10 6 to 77.0 ± 5.5 × 10 6 (Fig. 1 J) . Thus, RhoA deficiency results in acute multilineage cytopenia and a BM failure.
RhoA deficiency results in a loss of multilineage HPCs
Because RhoA loss reduced multiple blood lineages, we hy pothesized that RhoA signaling is critical for maintain ing HSPCs. To test this hypothesis, we initially performed colonyforming cell (CFC) assays to examine in vitro pro genitor activities. RhoA deficiency dramatically reduced the BM content of CFCs 5 d after poly I:C induction (0.013 ± 0.008% in RhoAcKO mice compared with 0.170 ± 0.024% in control mice, P < 0.001; Fig. 2 A) . Consistent with this result, we also observed a significant reduction of primitive LSK cells and less primitive progenitor LK cells in the RhoA cKO BM revealed by FACS analysis (Fig. 2, B 
RhoA deficiency reduces actomyosin signaling and SDF-1-driven chemotaxis
As shown in Figs. 1 and 2, by 5 d after poly I:C injections, RhoAdeficient hosts suffered a severe pancytopenia and BM failure, making this later time point unsuitable for mechanistic interpretation of RhoA signaling. To investigate the mechanism associated with the loss of HPCs upon RhoA gene deletion, we performed a time course study to identify the earliest time point at which RhoA was efficiently removed from Lin  BM cells. A reduction of RhoA protein was observed 2 d after poly I:C injections, but a complete KO of RhoA was not achieved until 3 d after injections (not depicted). Therefore, we chose to use mice 3 d after poly I:C injections for the fol lowing experiments.
RhoA is involved in regulating cellular adhesion and mi gration, which are relevant to HSPC niche residency and maintenance (Yoder and Williams, 1995) . Multiple molecular players in these pathways are regulated by RhoA. RhoA is a critical regulator of actomyosin activity, primarily through its downstream effectors ROCK (Kimura et al., 1996; Maekawa et al., 1999) and citron kinase (Yamashiro et al., 2003) . Con sistent with previous studies in other tissues Jackson et al., 2011) , RhoA deficiency led to a dramatic reduction of phosphorylated MLC in the isolated Lin  cells (Fig. 5 A) , suggesting a deficiency in actomyosin machinery in the HPC population. In addition to pMLC regulation, RhoA is also known to be a critical factor in regulating actin microfilament polymerization/stability through regulating mammalian diaphanous (mDia) and ROCK (Jaffe and Hall, 2005) . Surprisingly, cofilin activity, which destabilizes actin filament, was unchanged after RhoA deletion (Fig. 5 B) . Actin polymerization was increased, rather than reduced, in RhoA deficient cells (Fig. 5, C and D) . RhoA deficiency also led to an 50% reduction of SDF1-driven chemotaxis (Fig. 5 E) , consistent with the reduced pMLC activity (Fig. 5 A) . Un expectedly, RhoA loss increased, rather than decreased, the adhesion of Lin  cells to a fibronectincoated surface (Fig. 5 F) . It is unlikely that changes in the pathways regulating adhesion primitive LSK population. The frequency of RhoAnull LSK cells was not significantly different from the control group, and more importantly, they were capable of engrafting into secondary recipients (Fig. 4 , A and C). Efficient deletion of RhoA in the donorderived (CD45.2 + ) LSK population was confirmed by PCR (Fig. 4 E) . Furthermore, loss of RhoA did not alter the frequency of CD45.2 + cells in the HSC enriched LSKCD150 + population (93.3 ± 18.0% in the RhoA cKO group compared with 99.4 ± 4.0% in control mice; Kiel et al., 2005) , indicating that RhoA might be dispensable for longterm HSC maintenance (Fig. 4, A and D) .
To formally demonstrate the functionality of RhoAnull phenotypic HSCs, we performed a rescue experiment to see whether expressing RhoA in RhoA / LSK cells was able to restore multilineage hematopoiesis. We isolated LSK cells from poly I:C-injected competitive transplanted recipients and transduced them with lentivirus expressing human RhoA cDNA or control virus. These viruses also expressed eGFP as a reporter for transduction. The cells were transplanted into lethally irradiated CD45.1 + recipients without purifying for the eGFP + cells. Contributions of corrected RhoA / cells to hematopoiesis were determined by percentage of CD45.2 + cells within the eGFP + populations. Transduction with RhoA expressing lentivirus, not the control virus, was able to com pletely rescue the multilineage differentiation defects of the RhoA / LSK donor cells. The percentages of CD45.2 + Gr1 + myeloid cells, B220 + B cells, and CD3e + T cells within RhoA lentivirus-transduced RhoA / group were comparable with that of the RhoA fl/fl groups transduced with either RhoA or control virus, whereas little or no CD45.2 + myeloid, B, or T cells were observed in the control virus-transduced RhoA / group (Fig. 4 F) , indicating that the RhoA / LSK cell popu lation still contained HSC activity. Because hematopoiesis was sustained by WT competitor cells in the competitive trans plant model, these phenotypes reflected the HSCintrinsic effects of RhoA deficiency. The results show that RhoA is ab solutely required in HPCs but, surprisingly, is dispensable for maintaining HSCs. whether RhoA deficiency alters cell proliferation in our ge netic deletion model, we performed a BrdU incorporation assay to determine the distribution of RhoA / cells in the distinct stages of the cell division cycle (G 0 /G 1 and S, G 2 /M phase). In the noncompetitive transplantation model, a signif icant increase of BrdU + cells in both LSK and LK populations was observed 3 d after poly I:C induction (Fig. 6 A) . How ever, the increased proliferation in this model is likely a sec ondary effect caused by the acute hematopoietic stress seen upon RhoA deletion. We observed no change in BrdU incorporation when cells from the competitive transplantation recipients were analyzed, which served as a homeostatic hematopoiesis model (Fig. 6 B) . These results indicate that RhoA is not es sential for regulating the G 1 /S transition of steadystate hema topoietic progenitors. and migration are the primary driving force in loss of HPCs and HPC differentiation in response to RhoA deficiency.
RhoA regulates cytokinesis of HPCs through the ROCK and mDia pathways
A previous study has shown that suppression of RhoA via a dominantnegative mutant approach results in increased HSPC proliferation and engraftment (Ghiaur et al., 2006) . However, recent studies in Rho GTPases have revealed that overexpression of dominantnegative mutants may produce nonspecific biological responses as a result of the inherent nonspecific biochemical function of the mutants that are capa ble of sequestering multiple endogenous Rho, Rac, and/or Cdc42activating guanine nucleotide exchange factors (Wang and Zheng, 2007; Heasman and Ridley, 2008) . To examine Interestingly, a significant accumulation of G 2 /M HPCs upon RhoA deletion was observed (Fig. 6 A) . Recent genetic studies have emphasized the critical function of RhoA during mitosis in different biological contexts (Jackson et al., 2011; Melendez et al., 2011) . To examine whether mitosis is defective in the RhoAdeficient HPCs, we purified LK cells and mor phologically analyzed their nuclear contents. Similar to what has been reported in keratinocytes and mouse embryonic fi broblasts (Jackson et al., 2011; Melendez et al., 2011) , RhoA deficiency resulted in an 10fold elevation of multinucle ated cells (Fig. 6 C) . The nuclei were well separated but not condensed, suggesting that cytokinesis, rather than karyokine sis, was impaired. Indeed, a closer examination of 4N LK cells found a major accumulation of anaphaselike cells, which usu ally coincided with cytokinesis (Shuster and Burgess, 1999) , whereas the frequency of metaphase cells was not significantly altered ( Fig. 6 D) , also suggesting a deficiency in later mitotic phases. Activation and localization of Aurora kinases, key mitoticrelated kinases inactivating RhoA until anaphase (Andrews et al., 2003) , were not affected by RhoA deficiency in all cell phases examined (Fig. 6 E) , suggesting that the cytoki nesis failure in response to RhoA deficiency is not caused by impaired Aurora kinase activity. These results indicate that RhoA is critical for regulating cytokinesis of hematopoietic progenitors through pathways other than Aurora kinase.
To dissect the downstream pathways involved in regulat ing cytokinesis of HPCs, we transduced control or RhoA cKO LK cells with virus overexpressing either WT RhoA or effector binding-deficient mutant forms of RhoA, including E40L (ROCK binding deficient; Sahai et al., 1998) , R68A (mDia binding deficient; Rose et al., 2005) , and Y42C (protein kinase N [PKN] binding deficient; Sahai et al., 1998; Fig. 6 F) . As predicted, expression of WT RhoA was able to rescue the accumulation of multinucleated cells (Fig. 6, G and H) . Ex pression of Y42CRhoA was also able to rescue the cytokinesis failure phenotype (Fig. 6, G and H) , indicating RhoA-PKN interaction is not essential for cytokinesis. In contrast, expres sion of E40L and R68A RhoA was not sufficient to fully res cue the cytokinesis defects in RhoAdeficient cells (Fig. 6 , G and H), indicating that both RhoA-ROCK and RhoAmDia pathways are important for cytokinesis of HPCs.
RhoA deficiency causes programmed necrosis but not apoptosis or autophagy in the multipotent progenitor population Regulation of apoptosis is essential for the maintenance of HSPCs (Domen and Weissman, 1999) . Recent findings have indicated that molecules regulating autophagy, in addition to apoptosis, are also important for HSPC maintenance (Mortensen et al., 2011) . Although necrosis has initially been postulated as an accidental and unregulated cellular event, accumulating evidence suggests that necrosis can also be tightly regulated (Galluzzi and Kroemer, 2008) , but its molecular mechanism remains elusive and its role in the maintenance of HSPCs remains unclear. (Fig. 7 I ; Vandenabeele et al., 2010) , suggesting that RhoA deficiency is associated with an increase of TNFRIPmediated programmed necrosis cascade. Interestingly, we observed a strong positive correlation between necrosis and mitotic failure (Fig. 7 J) , implying that these cellular de fects are closely associated. Finally, in addition to rescuing multilineage hematopoiesis potential (Fig. 4 F) , expressing WT RhoA was also able to rescue the increased necrosis phenotype within RhoA / LK population in the competi tive transplant setting (Fig. 7 K) .
DISCUSSION
Rho family GTPases are well recognized intracellular signaling molecules, integrating a variety of signals to regulate multiple cellular processes, including cytoskeleton arrangement, gene expression, and cell cycle progression (Jaffe and Hall, 2005) . The Rho GTPases Rac1, Rac2, RhoH, and Cdc42 have been genetically demonstrated to be uniquely involved in HSPC maintenance and homing/engraftment activities (Gu et al., 2003; Cancelas et al., 2005; Yang et al., 2007a,b; Chae et al., 2008) . A previous study using a dominantnegative mutant of RhoA overexpression approach found that inhibition of RhoA activity enhanced HSPC proliferation and engraft ment activities (Ghiaur et al., 2006) . However, general concerns about a dominantnegative mutant overexpression approach, including a lack of specificity and dosage dependency and thus questionable physiological relevance, complicate a clear interpretation of such studies. Models in which RhoA is ge netically deleted are valid experimental systems to define the role of RhoA in tissue/cell type-specific functions under physiological conditions. RhoA is best appreciated as a key regulator of actomyosin, the signal effects of which are involved in adhesion, migration, mitosis, and gene expression. RhoA regulates actin polymer ization through mDia and ROCK (Narumiya et al., 1997) . Additionally, RhoA is critical for the spatial organization of actin filaments through ROCK and citron kinase-mediated MLC phosphorylation (Yamashiro et al., 2003; Matsumura, 2005) . In this study, we found that RhoA deficiency in HPCs
The reduction of RhoAnull HPCs could be the result of decreased survival or other defects in response to cytokinesis failure. Consistent with a specific loss of LK cells, we observed a specific increase of cell death in the LK population (Annexin V/7AAD staining; Fig. 7 , A-C). In contrast, the frequency of cell death in the more primitive LSK population was not statistically different from the control group (Fig. 7, A-C) . Similarly, in the competitive transplantation model, we observed an increase in cell death specifically in the donorderived RhoAnull LK population, suggesting that increased death is intrinsic to the RhoA / HPC population. However, the sur vival of RhoAnull LSK cells was comparable with the WT control counterpart (not depicted). Thus, RhoA is critical in regulating survival of LK cells, but not the more primitive LSK population.
The majority of dead RhoAnull cells were observed in the 7AAD + instead of Annexin V + population (Fig. 7 , A-C), which was unusual and suggested that the increased cell death might not be caused by apoptosis because Annexin V + stain ing is a hallmark of apoptosis, whereas 7AAD stains dead cells independently of the death mechanism. Consistent with this possibility, we found no evidence of caspase 3 cleavage in RhoAnull cells, by either Western blot or immunofluores cence (Fig. 7, D and E) . Additionally, we did not observe a reduction of prosurvival signals such as Bcl2, BclxL, and Survivin or an increase of proapoptotic proteins such as p53 (Fig. 7 F) , which was consistent with the involvement of a nonapoptotic cell death mechanism. There was also no change of the ratio between the two LC3B forms (Fig. 7 G) , the hall mark of autophagy, suggesting that autophagy was not involved either. Electron microscopic examination of RhoA / Lin  cells showed characteristics of necrosis, including the loss of membrane integrity and swelling of organelles (Fig. 7 H) , suggesting that the increased death of RhoA / HPCs is re lated to increased necrosis. Although necrosis has been viewed as an accidental process, recent studies implicate pathways such as the TNF-receptorinteracting protein kinase (RIP) pathway as critical for regulating programmed necrosis (Vandenabeele et al., 2010) . To examine whether the TNF-RIP pathway was altered in RhoAnull HPCs, we probed for expression of genes of this pathway. We noticed increased tations were performed similarly as described in Fig. 3 . Samples were analyzed 5 mo after secondary transplantation. BrdU injection at 0.5 mg/recipient was performed 30 min before experiment. deletion. Together with data from other RhoA cKO models, our results highlight the diverse and contextdependent func tions of RhoA and the uniqueness of RhoA GTPase in the primitive hematopoietic compartment. The findings suggest results in reduced MLC activity, yet RhoA signaling is dis pensable for Factin microfilament polymerization. We found that cytokinesis and migration, two cellular processes using myosin machinery as a driving force, are defective upon RhoA rather than metaphase or telophase cells. Interestingly, nuclei of the phenotypic anaphase cells are surrounded by Lamin B-labeled nuclear envelopes (unpublished data), which should only reform during or after telophase, suggesting the accu mulation of anaphase cells is not because of blockage at the anaphase-telophase transition but rather is likely caused by a regression of cleavage furrow during cytokinesis. Whether the suppression of MLC activity in response to the loss of RhoA in HPCs directly contributes to the cytokinesis failure phenotype, as described for megakaryocytes, will need to be further investigated.
Cytokinesis failure can trigger aberrant segregation of chro mosomes and activate cell death pathways (Castedo et al., 2004a,b) . Increased necrosis, but not apoptosis or autophagy, is observed coinciding with the cytokinesis failure after RhoA deficiency. Differing from megakaryocytes, which undergo endomitosis and presumably obtain a unique mechanism to sustain survival, HPCs are normally diploid and lack the ability to withstand the stress from polyploidy and therefore undergo cell death. Consistent with the possibility that RhoA loss may induce a genomic stress from polyploidy of the cytokinesis blockage, a transcriptome analysis revealed an increase of the expression of DNA damage/repair pathway genes in the RhoA null LK population (unpublished data). Interestingly, the cor relating result of such cytokinesis arrest and genomic stress from the loss of RhoA is manifested by overexpression of multiple components of the TNF-RIPmediated program necrosis pathway and phenotypic necrosis, rather than apop tosis or autophagy. Although poly I:C used in this study to induce the deletion of RhoA is known to trigger a transient increase of TNF-RIPmediated necrosis (Penning et al., 1998) , the observed necrosis after RhoA deficiency is not caused by a side effect of poly I:C treatment. In the competitive trans plantation model, an increase of necrosis in the HPC popula tion is observed 5 mo after secondary transplantation when any poly I:C effects should have been long gone. We conclude that the TNF-RIPmediated necrosis of HPCs may be a con sequence of RhoA deficiency and cytokinesis arrest.
In summary, we demonstrate that RhoA deficiency leads to acute BM failure and pancytopenia. RhoA signaling is re quired for HPC cell cycle progression but not HSC engraft ment, and deletion of RhoA results in cytokinesis failure in HPCs. Interactions between RhoA and its downstream effec tors ROCK and mDia appear to be critical signaling events as interruption of these interactions cause cytokinesis arrest. Cytokinesis failure in HPCs in response to the loss of RhoA is followed by programmed necrosis possibly involving TNF-RIP signaling. It is likely that RhoAregulated HPC cytoki nesis and the associated programmed necrosis are an underlying mechanism of HPC homeostasis and that HSCs and HPCs are equipped with distinct mechanisms involving RhoA to control cell division and death.
MATERIALS AND METHODS
Mice. C57BL/6 × B129 mixed background RhoA fl/fl mice were generated as previously described (Melendez et al., 2011) and crossed with Mx-cre mice. 6-8wkold Mx-Cre + RhoA fl/fl and Mx-cre  RhoA fl/fl mice were used throughout that despite the commonalities shared by different Rho GT Pases, such as structures, regulators, and effectors, the physio logical function of each Rho GTPase can be unique and context specific.
In the present study, we demonstrate that RhoA is critical for multilineage hematopoiesis, the regulation of mitosis of HPCs, and the survival of the progenitors via regulation of programmed necrosis. Recent studies are consistent with our findings of a critical, but cell type-specific role for RhoA in hematopoiesis, in which a role of RhoA in the terminal dif ferentiation of mature hematopoietic cells has been shown. Deletion of RhoA in B cells using CD19Cre blocks B cell differentiation without affecting proliferation (Zhang et al., 2012) . Megakaryocytespecific RhoA deletion using PF4Cre causes macrothrombocytopenia and generates defective plate lets (Pleines et al., 2012) . Additionally, our unpublished data using T cell-and erythroidspecific RhoA KO models indi cate that RhoA is critical for T and red blood cell differentiation and function, although via different mechanisms at different cell differentiation stages. It will be of great interest to charac terize the function of RhoA in other hematopoietic lineages using the cKO genetic models.
One striking finding of our study is that RhoA is abso lutely required in HPC survival and the subsequent produc tion of mature blood cells, but it is dispensable for the longterm maintenance of HSCs. RhoA, to our knowledge, is the first molecule identified to be specifically required for the regula tion of multilineage progenitor cells but not the stem cells. There are several possible mechanisms accounting for this dif ferential requirement of RhoA. Although no increased activ ity/expression of closely related RhoB/RhoC was observed upon RhoA deficiency, endogenous RhoB/RhoC activities might be sufficient to maintain the stem cells but not enough to rescue the deficiency of RhoA in HPCs. Alternatively, the different behaviors of RhoA / HSCs and HPCs could re flect the intrinsic difference between the two cell populations. Additional signals within the HSC population might not need RhoA signaling, but the RhoA pathways are turned on upon HSC differentiation to HPCs. Should this be the case, it will be interesting to identify the signaling pathways responsible for this difference. Another possibility is that the difference between RhoAnull HSCs and HPCs may come from the distinct cell cycle division kinetics and history of the two populations. Therefore, the faster and/or more divisions a cell goes through, the higher the likelihood of its experiencing a cytokinesis failure in response to loss of RhoA. Because HPCs commonly go through faster and more cell cycles than stem cells, they could more be vulnerable to cytokinesis failure.
Previous studies on endomitotic megakaryocytes suggest that the generation of 4N megakaryocytes from 2N cells is caused by the failure of the MLCdriven late ingression rather than the initial formation of cleavage furrow, which is followed by a backward movement and refusion of the two daughter cells (Geddis et al., 2007; Lordier et al., 2008) . Similar to the endomitosis of megakaryocytes, in the RhoAnull HPCs we have observed a significant accumulation of anaphase cells, Gr1 (RB68C5), Ter119 (TER119), APCconjugated antiBrdU, cKit (2B8), B220 (RA36B2), CD11b (M1/70), APCCy7-conjugated antiCD45.2 (104) streptavidin, PEconjugated anti-Sca1 (D7), CD135 (A2F10.1), CD45.1 (A20), FITCconjugated antiCD41 (MWReg30), CD48 (HM481), CD45.2 (104), PercpCy5.5-conjugated streptavidin, PECy7-conjugated anti-Sca1 (D7), CD45.2 (104; BD), FITCconjugated antiCD34 (RAM34), FcRII/III (93), APCCy7-conjugated antiIL7R (A7R34; eBioscience), and PECy7-conjugated antiCD150 (TC1512F12.2; BioLegend).
Cell cycle analysis was performed using Hoechst 33342 (Invitrogen), PI/RNase staining buffer, or BrdU Flow kit (BD). Apoptosis was analyzed using the Annexin V Apoptosis Detection kit (BD) according to the manu facturer's protocol. Cell death was detected by 7AAD staining (BD). Corti cal Factin was stained by Alex Fluor 488-phalloidin (Invitrogen).
Flow cytometry analysis was performed using FACSCanto II, FACS Canto III, or LSR II cytometry (BD), and data were analyzed using either FACSDiva (BD) or FlowJo software (Tree Star). Cell cycle distribution was calculated by FlowJo software using the Watson model. ImageStream data were acquired using ImageStream flow cytometry (Amnis) using 40× objec tive, and data were analyzed using IDEAS software (Amnis).
Isolation of HSPCs.
To isolation of HSCs and progenitors, Lin  cells were enriched using a Lineage Cell Depletion kit (Miltenyi Biotec) according to the product manual. Isolated cells were then stained with biotinlabeled B220, CD3e, CD4, CD8, CD11b, Gr1, and Ter119 antibodies, followed by APCCy7-streptavidin, PECy7-Sca1, APCCD117, FITCCD34, and PECD135 for isolation of different HSC populations or APCCy7-streptavidin, PE-Sca1, APCCD117, PECy7-FcRII/III, and FITCCD34 for isolating different myeloid progenitor populations. The FACSAria II (BD) was used to perform the isolation.
Microscopy. For immunofluorescent microscopic experiments, FACSisolated cells were cultured in Iscove's modified Dulbecco's medium (IMDM; Invitro gen) with 10% FBS, 50 U/ml penicillin, 50 µg/ml streptomycin, 100 ng/ml rmSCF, recombinant human thrombopoietin (rhTPO; PeproTech), and re combinant human granulocyte colony stimulating factor (rhGCSF; Amgen Inc.) on CH296 (Takara Bio Inc.)-coated coverslips overnight and then fixed with 4% paraformaldehyde (Electron Microscopy Sciences) at room tempera ture for 15 min. Fixed cells were permeabilized with 0.2% TritonPBS for 20 min and stained with primary antibodies overnight and secondary antibodies for 1 h. Antibodies and dyes used include anti-tubulin (SigmaAldrich), anti-Lamin B (M20; Santa Cruz Biotechnology, Inc.), anti-Cleaved Caspase 3, anti-phosphorylated Aurora A/B/C (Cell Signaling Technology), Alexa Fluor 488 goat anti-mouse IgG (H+L), goat anti-rabbit IgG (H+L), Alexa Fluor 555 donkey anti-goat IgG (H+L), and DAPI (Invitrogen). Samples were mounted using VECTASHIELD Mounting Medium (Vector Laborato ries). Slides were imaged on an LSM710 LIVE Duo Confocal Microscope at 40×/1.1 LD CApochromat (water immersion) objective (Carl Zeiss) at room temperature using the LSM710 Point Scanner (Carl Zeiss). Images were taken and analysis using Zen 2011 software (Carl Zeiss).
For H&E and Hema3 staining, cells and tissues were mounted using Permount Mounting Medium (Thermo Fisher Scientific) and imaged on a Motic BA310 microscope (Ted Pella) using a CCIS EFN Plan Achro matic 40×/0.65 and 100×/1.25 objectives at room temperature by Moti cam 580 camera (Ted Pella). Images were taken using Mitic Image Plus (Ted Pella) software and processed using ImageJ software (National Institutes of Health).
For electron microscopic analysis, isolated Lin  cells were fixed by 2.5% glutaraldehyde (Electron Microscopy Sciences) in PBS overnight. Cells were embedded in low melting temperature agarose, postfixed in 2% osmium tet roxide with 1.5% potassium ferrocyanide, 4% uranyl acetate solution, and then dehydrated by a series of ethanol solution and propylene oxide. Fixed cells were embedded in resin (Embed 812; Electron Microscope Sciences). Ultrathin (90 nm) sections were prepared by an ultramicrotone (Ultra Cut E; ReichertJung), and electron microscopic pictures were taken using an elec tron microscope (H7600; Hitachi HighTechnologies America). this study. Two to three doses of poly I:C (Amgen Inc.) were administrated intraperitoneally to both mutant and littermate control mice on alternate days (10 µg/gram body weight). Time points are expressed as days after the final injection. Mice were bred and housed in a pathogenfree facility at Cincinnati Children's Hospital Medical Center in compliance with the Cincinnati Chil dren's Hospital Medical Center Animal Care and Use Committee protocols.
Transplantation assays. For congenic transplantation experiments, 3 × 10 6 BM cells from CD45.2 + RhoA fl/fl Mxcre + or Mxcre  mice were trans planted into lethally irradiated CD45.1 + C57BL/6J WT recipients through the tail vein. After 8 wk of hematopoiesis, recipients were subjected to poly I:C injections, and samples were collected for analysis. Experiments were replicated twice.
For competitive transplantation experiment, 3 × 10 6 CD45.2 + RhoA fl/fl Mxcre + or Mxcre  BM cells were mixed with an equal amount of CD45.1 + WT BM cells and transplanted into lethally irradiated CD45.1 + BoyJ WT recipients via the tail vein. After 8 wk, three doses of poly I:C were adminis trated, and PB samples were collected monthly for chimeric analysis. 4 mo after the poly I:C induction, recipients were sacrificed and 3 × 10 6 BM cells were transplanted into lethally irradiated secondary BoyJ recipients. PB chi merisms were checked monthly in the secondary recipients for at least 4 mo. Experiments were repeated three times, and at least four recipients were used for each genotype for each experiment.
For in vivo rescue experiments, lethally irradiated CD45.1 + primary recipients were reconstituted with 3 × 10 6 CD45.2 + RhoA fl/fl Mxcre + or MxCre  donor BM cells together with an equal amount of CD45.1 + WT competitor BM cells. Three poly I:C injections were administered 6 wk after transplantation, and PB samples were collected to ensure RhoA deletion had occurred in the CD45.2 + RhoA fl/fl Mxcre + (in contrast to intact RhoA in the RhoA fl/fl Mxcre  ) donor-derived cells, whereas CD45.1 + competitorderived cells were not affected. These primary recipients were sacrificed, and BM LSK and LK cells were isolated via immunemagnetic separation and FACS. LSK cells were transduced with a lentivirus vector expressing human RhoA and eGFP cDNA, or the control eGFP cDNA, driven by a ubiqui tously expressing modified viral promoter, MND (Challita et al., 1995) . In brief, LSK cells (mixture of CD45.2 + donor cells and CD45.1 + competitor cells) were prestimulated overnight in StemSpan SFEM medium (STEMCELL Technologies) supplemented with 2% fetal calf serum, 1% penicillin/strepto mycin, 50 ng/ml recombinant murine SCF (rmSCF), 10 ng/ml mouse IL3 (mIL3), 1 mM deoxyribonucleotide triphosphate (dNTP), and 40 µg/ml lowdensity lipoprotein LDL (SigmaAldrich). LSK cells were transduced with either RhoA or GFPexpressing lentivirus vector at a multiplicity of infection of 25, twice separated by 8-12 h. Sorted LK cells were also cultured separately under the same cytokine conditions without any viral transduc tion. Approximately 10,00020,000 transduced LSK cells were cotransplanted with 25,000-50,000 untransduced irradiated LK cells as carrier cells into lethally irradiated CD45.1 + secondary recipients. PB and BM samples were obtained monthly to analyze CD45.2 + cells of different hematopoietic lin eages that expressed eGFP. Survival data shown in Fig. 7 K were obtained at 8 mo after transplantation. Experiments were performed twice, and at least four recipients were used for each condition for each experiment.
Hematologic analysis. Mice were anesthetized and bled through the tail vein into EDTAcoated tubes (BD). Complete blood counts were analyzed using Hemavet 850 (Drew Scientific). BM cytospin slides were stained using Hema3 system (Thermo Fisher Scientific). Bone, spleen, and liver tissues were fixed in 10% formalin and stained with H&E.
Flow cytometry. BM cells were flushed from long bones (tibias, femurs, and iliac crests) with PBS (Invitrogen) plus 1% heatinactivated FBS, 50 U/ml penicillin, and 50 µg/ml streptomycin and filtered through a 45µm cell strainer (BD) to obtain singlecell suspensions. Red blood cells were lysed with Cell Lysis Buffer (BD).
Antibodies used in this study include: biotinlabeled antiB220 (RA3 6B2), CD3e (1452C11), CD4 (RM45), CD8 (536.7), CD11b (M1/70),
In vitro viral transduction. For retrovirus production, REW13 empty vector or REW13 vectors overexpressing WT RhoA or effector binding mutant forms of RhoA (E40L, Y42C, and R68A) were transfected into HEK 293T cells using the calcium phosphatase precipitation method. Viral super natant was harvested at days three and four of transfection. LK cells were cul tured in IMDM supplemented with 10% FBS, 50 U/ml penicillin, 50 µg/ml streptomycin, 100 ng/ml rmSCF, rhTPO (PeproTech), and rhGCSF (Amgen Inc.) for 2 d before transduction. Viral particles were enriched by 20 µg/ml recombinant fibronectin CH296 (Takara Bio Inc.). Stimulated LK cells were transduced for 24 h and further cultured free of virus for an additional 24 h before analysis.
Colony-forming units assay. 50,000 BM cells were seeded in cytokine supplemented MethoCult GF M3434 medium (STEMCELL Technologies) for 7 d, and colonies were enumerated based on size and morphology.
Adhesion and migration assays. For adhesion assay, 10 5 Lin  cells were cultured at 37°C in CH296-coated 96well plates in 10% FBS supple mented IMDM for 2 h. Nonadherent cells were removed by 2× PBS wash. Adherent cells were recovered by 10min trypsin treatment, and the number of adherent cells was counted.
For migration assay, 10 5 Lin  cells were cultured in the top chamber of Transwell (Corning) in IMDM with 0.5% BSA (SigmaAldrich). 100 ng/ml SDF1 (PeproTech) was added into the bottom chamber as a chemoat tractant cue. 4 h later, cells migrated into the bottom chamber were collected for enumeration.
Protein activity and expression assays. For Rhotekin RBD pulldown assay, isolated Lin  cells were starved overnight and stimulated with 10 ng/ml SCF or SDF1 or transferred onto a 20 µg/ml CH296-coated nontissue culture dish for 10 min at 37°C. GTPbound RhoA was pulled down and analyzed using Rhotekin RBD Agarose Beads (Cell Biolab, Inc.) according to the product manual.
For protein expression analysis, isolated Lin  cells were lysed by RIPA buffer (Cell Signaling Technology) according to the manufacturer's protocol. 10-50 µg of total protein was loaded depending on antigen level/antibody quality for Western blot analysis. Antibodies used include RhoA (67B9), RhoB, RhoC (D40E4), phosphorMLC (Ser19), total MLC, phosphor cofilin (Ser3), cofilin, Cleaved Caspase3 (Asp175), Bcl2, BclxL, Sur vivin, p53, LC3B (Cell Signaling Technology), and Lamin B (M20; Santa Cruz Biotechnology).
Transcript expression. Total RNA was extracted from FACSisolated HSPCs using an RNeasy Micro kit (QIAGEN) according to the manufac turer's manual. Complementary DNA was generated using the High Capac ity cDNA kit (Life Technologies). Mouse TaqMan assays used in this study were purchased from Applied Biosystems: Tnf (Mm00443260_g1), Tnfsf1B (Mm00441889_m1), Ripk1 (Mm00436354_m1), Ripk3 (Mm01319233_g1), Hsp90aa1 (Mm00658568_gH), Fth1 (Mm00850707_g1), Glud1 (Mm00492353_m1), and Gapdh (Mm99999915_g1). All experiments were performed in triplicate using the Ct method, and differences in cDNA concentration were nor malized against endogenous Gapdh level.
Data analysis.
Results are shown as mean ± SEM from at least three indi vidual experiments per group. Statistical analysis between control and RhoA cKO was assessed by an unpaired, twotail Student's t test except for the phase distribution of mitotic cells (Fig. 6 G) , which is assessed by a  2 test. *, P < 0.05; **, P < 0.01; ***, P < 0.001, except for Fig. 3 , in which *, P < 0.001.
